Sam Fazeli is a senior analyst and the EMEA head of Bloomberg Intelligence, a dynamic platform for in-depth research available on the Bloomberg Professional service at BI.
Dr. Fazeli specializes in European pharmaceuticals and biotechnology.
Dr. Fazeli has over 20 years of experience conducting equity research as a pharmaceutical analyst, working at firms such as Nomura International and HSBC.
Prior to joining Bloomberg in 2010, Dr. Fazeli worked at Piper Jaffray, Ltd. as a pharmaceutical analyst and head of European research. Before transitioning to investment banking, Dr. Fazeli was a research scientist for seven years.
Dr. Fazeli has been ranked a top analyst by both the U.K. and Pan-European Extel surveys. He received a bachelor’s of science from Cardiff University, and a Ph.D. in pharmacology from the University of London.